Drug Pricing

Business & Economics

Who’s Afraid of Anti-Inversion Rules?

Swift and merciless. That was the apparent effect the U.S. Treasury’s April 4 regulatory package had on what was poised to be the largest inversion in history. But several pending inversions have emerged relatively unscathed, and experts are predicting continued corporate exodus, raising questions about what exactly Treasury has accomplished. ...
Commentary

Trump and Obama promise to be terrible negotiators

President Barack Obama and presidential hopeful Donald Trump don’t agree on much. But they’ve found common ground in pushing to upend the Medicare drug benefit. At a rally days before his resounding victory in New Hampshire, Trump grumbled about government drug spending — and called for Medicare to take over ...
Commentary

Hillary’s Price Controls Would Kill New Drug Innovation

Like your iPhone? Federal officials designed it. Couldn’t live without the Internet? Thank Uncle Sam — he invented it. Sick and need new medicine? Don’t worry — the government is here to help. This fantastical line of thinking — that because the government funded basic, early-stage research, it can claim ...
Commentary

To control drug prices, pursue fraud, not manufacturers

A Los Angeles-based nonprofit has gathered enough signatures to get two initiatives on the November ballot. The one of greater interest to ordinary Californians would legislate that any prescription drug paid for with state money cost no more than the amount paid by the Veterans Administration. The California Drug Price ...
Commentary

Clinton would drive up health care costs

Five years and nine months after its passage, the federal government has issued more than 10,000 pages of regulations related to the implementation of Obamacare. Get ready for several thousand more pages if Hillary Clinton takes the White House. She’s proposing a raft of new government mandates to “protect the ...
Commentary

The Senate should reject foreign drug importation

Congress must send a budget to President Obama by next Friday. Senate lawmakers, hoping to avoid a government shutdown, have just started sparring over the details of their reconciliation measure. Sen. John McCain (R-Ariz.) has introduced an amendment to legalize the importation of certain prescription drugs from abroad. On the ...
Commentary

Pharmaceutical Price Controls Risk Future Cures

Recent reports of significant price increases for certain medications have ignited, yet again, calls for pharmaceutical price controls. If implemented, price controls will reduce medical discovery and diminish patients’ access to life saving medicines. Pharmaceutical innovations help patients and strengthen the U.S. economy Pharmaceutical innovations are improving the quality of ...
Commentary

Uncle Sam Can’t haggle better than private insurers

The White House is declaring war on prescription drug prices. “The administration is deeply concerned with the rapidly growing prices of specialty and brand name drugs,” notes President Obama’s 2016 budget proposal. To keep prices down, the president wants the government to negotiate prices for drugs dispensed through Medicare. But ...
Commentary

Don’t let artificial caps stifle drug production

This is shaping up to be another banner year for medical progress. Regulators have already approved 28 new medicines, roughly on last year’s pace of 41 new drug approvals – the most since the Clinton administration. But in future years, the list of medical breakthroughs could prove much shorter. In ...
Commentary

Bernie Sanders’ ‘Medicare For All’ Would Be A Disaster For All

This month, Bernie Sanders took his vision for the future of American health care to a national television audience in the first Democratic presidential debate. “We should look to countries like Denmark, like Sweden and Norway and learn from what they have accomplished,” Sanders said. He wants the United States ...
Business & Economics

Who’s Afraid of Anti-Inversion Rules?

Swift and merciless. That was the apparent effect the U.S. Treasury’s April 4 regulatory package had on what was poised to be the largest inversion in history. But several pending inversions have emerged relatively unscathed, and experts are predicting continued corporate exodus, raising questions about what exactly Treasury has accomplished. ...
Commentary

Trump and Obama promise to be terrible negotiators

President Barack Obama and presidential hopeful Donald Trump don’t agree on much. But they’ve found common ground in pushing to upend the Medicare drug benefit. At a rally days before his resounding victory in New Hampshire, Trump grumbled about government drug spending — and called for Medicare to take over ...
Commentary

Hillary’s Price Controls Would Kill New Drug Innovation

Like your iPhone? Federal officials designed it. Couldn’t live without the Internet? Thank Uncle Sam — he invented it. Sick and need new medicine? Don’t worry — the government is here to help. This fantastical line of thinking — that because the government funded basic, early-stage research, it can claim ...
Commentary

To control drug prices, pursue fraud, not manufacturers

A Los Angeles-based nonprofit has gathered enough signatures to get two initiatives on the November ballot. The one of greater interest to ordinary Californians would legislate that any prescription drug paid for with state money cost no more than the amount paid by the Veterans Administration. The California Drug Price ...
Commentary

Clinton would drive up health care costs

Five years and nine months after its passage, the federal government has issued more than 10,000 pages of regulations related to the implementation of Obamacare. Get ready for several thousand more pages if Hillary Clinton takes the White House. She’s proposing a raft of new government mandates to “protect the ...
Commentary

The Senate should reject foreign drug importation

Congress must send a budget to President Obama by next Friday. Senate lawmakers, hoping to avoid a government shutdown, have just started sparring over the details of their reconciliation measure. Sen. John McCain (R-Ariz.) has introduced an amendment to legalize the importation of certain prescription drugs from abroad. On the ...
Commentary

Pharmaceutical Price Controls Risk Future Cures

Recent reports of significant price increases for certain medications have ignited, yet again, calls for pharmaceutical price controls. If implemented, price controls will reduce medical discovery and diminish patients’ access to life saving medicines. Pharmaceutical innovations help patients and strengthen the U.S. economy Pharmaceutical innovations are improving the quality of ...
Commentary

Uncle Sam Can’t haggle better than private insurers

The White House is declaring war on prescription drug prices. “The administration is deeply concerned with the rapidly growing prices of specialty and brand name drugs,” notes President Obama’s 2016 budget proposal. To keep prices down, the president wants the government to negotiate prices for drugs dispensed through Medicare. But ...
Commentary

Don’t let artificial caps stifle drug production

This is shaping up to be another banner year for medical progress. Regulators have already approved 28 new medicines, roughly on last year’s pace of 41 new drug approvals – the most since the Clinton administration. But in future years, the list of medical breakthroughs could prove much shorter. In ...
Commentary

Bernie Sanders’ ‘Medicare For All’ Would Be A Disaster For All

This month, Bernie Sanders took his vision for the future of American health care to a national television audience in the first Democratic presidential debate. “We should look to countries like Denmark, like Sweden and Norway and learn from what they have accomplished,” Sanders said. He wants the United States ...
Scroll to Top